LCD L39680: MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy — Noridian
Policy LCD-L39680 · Pulmonology
New guidelines may improve billing for pulmonary nodule tests.
Code intelligence
R91.1 reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code R91.1.
Elevated code riskView ICD-10 detail
Signal breakdown
2 shown · 2 total in platform
Risk: Elevated
0
Critical
0%
2
High
100%
0
Routine
0%
0
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
High
LCD L39678: MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy — Noridian
Policy LCD-L39678 · Pulmonology
New MolDX guidelines will impact pulmonary nodule billing practices.
Audit documentation
Building an audit file that includes R91.1?
The Tripwire Audit Pack exports 12 months of Pulmonology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Pulmonology audit pack — $349One-time purchase · not a subscription